Advertisement

Topics

Ethris Enters Strategic Collaboration with AstraZeneca and MedImmune to Develop mRNA Therapies ...

21:06 EDT 20 Aug 2017 | BioMedReports - Blog

Ethris GmbH
Ilse Huebner-Seibl
+49-(0)89-8955-788 10
info@ethris.com
or
Media requests:
MacDougall Biomedical Communications
Mario Brkulj or Joanne Tudorica
Phone: +49 175 501 05 75 or +49 (0) 89 2424 3494
mbrkulj@macbiocom.com

Read more...

Original Article: Ethris Enters Strategic Collaboration with AstraZeneca and MedImmune to Develop mRNA Therapies ...

NEXT ARTICLE

More From BioPortfolio on "Ethris Enters Strategic Collaboration with AstraZeneca and MedImmune to Develop mRNA Therapies ..."

Advertisement
Quick Search
Advertisement
Advertisement